Most immune cells showed a positive correlation with risk scores, especially hematopoietic stem cells of XCELL, resting memory CD4+ T cells, activated mast cells, M2 macrophages of CIBERSORT-ABS, B cells of QUANTISEQ, and cancer-associated fibroblasts of MCPCOUNTER. The gene discussed is CD4; the disease is cancer.